Today: 9 June 2026
Browse Category

ASX:WAF 26 November 2025 - 1 December 2025

West African Resources (ASX: WAF) Share Price Outlook: Kiaka Stake Talks, Gold Production Surge and 2026 Forecasts

West African Resources (ASX: WAF) Share Price Outlook: Kiaka Stake Talks, Gold Production Surge and 2026 Forecasts

West African Resources shares dropped 13–15% after trading resumed on the ASX in late November 2025, following a suspension tied to Burkina Faso’s demand for a larger stake in the Kiaka gold project. The company’s market value stood near A$3.1–3.2 billion, with shares at A$2.81, down from recent highs. The stock had delivered a five-year total return of 188% before the recent volatility.
1 December 2025
West African Resources (ASX: WAF) Share Price Today, 28 November 2025 – Gold Miner Steadies as Burkina Faso Stake Talks Stay in Focus

West African Resources (ASX: WAF) Share Price Today, 28 November 2025 – Gold Miner Steadies as Burkina Faso Stake Talks Stay in Focus

West African Resources shares closed at A$2.75 in Sydney on Friday, up 1.5% for the day but still down about 9% from a week ago after resuming trade following a three-month suspension. The stock remains below pre-halt levels amid ongoing political risk in Burkina Faso. Trading volume was heavy, with prices moving between A$2.65 and A$2.82. Market cap stands near A$3.1 billion.
28 November 2025
West African Resources (ASX:WAF) share price holds ground after post‑halt plunge – ASX gold stock update for 27 November 2025

West African Resources (ASX:WAF) share price holds ground after post‑halt plunge – ASX gold stock update for 27 November 2025

West African Resources shares held at A$2.75 in early Sydney trading Thursday, unchanged after a sharp drop on Wednesday following a three-month suspension. The stock remains about 10–16% below its pre-halt level amid uncertainty over the Burkina Faso government’s push to increase its stake in the Kiaka gold project. No new company announcements were issued Thursday.
26 November 2025
Australian Stock Market Today: ASX 200 Climbs 0.8% as Takeover Deals, CPI Shock and Retail Rout Shape 26 November 2025

Australian Stock Market Today: ASX 200 Climbs 0.8% as Takeover Deals, CPI Shock and Retail Rout Shape 26 November 2025

The S&P/ASX 200 rose 0.81% to 8,606.5 Wednesday, shrugging off a jump in annual inflation to 3.8%. Temple & Webster plunged 32% after weak revenue growth, while National Storage REIT surged nearly 20% on a $4 billion takeover bid. The Australian dollar climbed to US$0.6505. Miners and healthcare stocks led gains.
WAF Stock Today (ASX:WAF): West African Resources Plunges 16% as Burkina Faso Stake Talks Reignite – November 26, 2025

WAF Stock Today (ASX:WAF): West African Resources Plunges 16% as Burkina Faso Stake Talks Reignite – November 26, 2025

West African Resources closed down 15.8% at A$2.56 on November 26, 2025, after trading resumed following a multi-month ASX suspension. The sell-off came as investors reacted to Burkina Faso’s push for a 50% stake in WAF’s flagship Kiaka gold mine. Trading volume surged to 14.7 million shares, more than double the three-month average.
26 November 2025

Stock Market Today

  • Two Covered-Call Dividend Funds Offering 8%+ Yields Amid Market Volatility
    June 9, 2026, 11:05 AM EDT. Investors seeking steady income during market volatility should consider two covered-call funds yielding over 8%. The Nuveen S&P 500 Dynamic Overwrite Fund (SPXX), for example, offers a 9.2% dividend by selling call options on 35%-75% of its portfolio, generating premium income while holding familiar large-cap stocks like NVIDIA, Microsoft, JPMorgan Chase, and Pfizer. SPXX trades at an 11.4% discount to its net asset value (NAV), significantly below its five-year average, providing a discounted entry point. Covered-call strategies generate income by selling the right for others to buy fund stocks at a set price, benefiting in choppy markets but potentially capping gains during rallies. These funds provide reliable dividends, supporting investors through pullbacks without selling shares.

Latest articles

Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

9 June 2026
Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
Reddit Shares Pop After Wall Street Sees the Right Ad Signal

Reddit Shares Pop After Wall Street Sees the Right Ad Signal

9 June 2026
Reddit shares surged 6.6% to $182.44 after Cleveland Research and Piper Sandler cited stronger ad demand and raised revenue forecasts, with Cleveland noting 45% of advertisers beat ROI targets in Q2 and Reddit taking ad share from rivals, but risks remain around user growth, AI search traffic, and high valuation.
Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Go toTop